These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38348070)
81. Safety and Efficacy of Autologous Melanocyte/Keratinocyte Transplantation in Patients with Refractory Stable Vitiligo. Shahbazi A; Abedi Valugerdi M; Kazemi S; Samadi Kochaksaraei S; Naseh MH; Aghdami N; Sadeghi B Dermatology; 2023; 239(6):919-925. PubMed ID: 37573775 [TBL] [Abstract][Full Text] [Related]
82. Efficacy of Cyclosporine After Autologous Noncultured Melanocyte Transplantation in Localized Stable Vitiligo-A Pilot, Open Label, Comparative Study. Mutalik S; Shah S; Sidwadkar V; Khoja M Dermatol Surg; 2017 Nov; 43(11):1339-1347. PubMed ID: 28538030 [TBL] [Abstract][Full Text] [Related]
83. Assessment of CXCL10 Before and After Narrow Band UVB Phototherapy in Non-Segmental Vitiligo Patients. Hussein SM; Sorour MAEH; Samir M; Abd El Azim SA; Hossain A Indian J Dermatol; 2022; 67(4):319-323. PubMed ID: 36578753 [TBL] [Abstract][Full Text] [Related]
84. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377 [TBL] [Abstract][Full Text] [Related]
85. Heterologous Type I Collagen as an Add-on Therapy to Narrowband Ultraviolet B for the Treatment of Vitiligo: A Pilot Study. Gkouvi A; Nicolaidou E; Corbo A; Selvaggi G; Tsimpidakis A; Mastraftsi S; Gregoriou S J Clin Aesthet Dermatol; 2021 Jun; 14(6):31-34. PubMed ID: 34804353 [TBL] [Abstract][Full Text] [Related]
86. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population. Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632 [TBL] [Abstract][Full Text] [Related]
87. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. Li R; Qiao M; Wang X; Zhao X; Sun Q Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531 [TBL] [Abstract][Full Text] [Related]
88. Successful Treatment of Stable Vitiligo by Low-Density Cultured Autologous Melanocyte Transplantation Combined With Narrowband Ultraviolet B Therapy. Yao L; Liu Y; Song Y; Zhong S; Li S Dermatol Surg; 2017 Oct; 43(10):1281-1287. PubMed ID: 28445194 [TBL] [Abstract][Full Text] [Related]
89. Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis. Ju HJ; Bae JM; Lee RW; Kim SH; Parsad D; Pourang A; Hamzavi I; Shourick J; Ezzedine K JAMA Dermatol; 2021 Mar; 157(3):307-316. PubMed ID: 33595599 [TBL] [Abstract][Full Text] [Related]
90. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients. Adauwiyah J; Suraiya HH Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949 [TBL] [Abstract][Full Text] [Related]
91. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation. Mulekar SV Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186 [TBL] [Abstract][Full Text] [Related]
92. Twelve-month and sixty-month outcomes of noncultured cellular grafting for vitiligo. Gan EY; Kong YL; Tan WD; Thng ST; Goh BK J Am Acad Dermatol; 2016 Sep; 75(3):564-571. PubMed ID: 27180264 [TBL] [Abstract][Full Text] [Related]
93. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Mulekar SV Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183 [TBL] [Abstract][Full Text] [Related]
94. Intralesional methotrexate in the treatment of localized vitiligo: A pilot study. Elrewiny EM; Shawky A; Mohamed SFF; Ammar AM; Mansour M; Rageh MA Australas J Dermatol; 2023 Aug; 64(3):e207-e211. PubMed ID: 37166107 [TBL] [Abstract][Full Text] [Related]
95. Effect of Procedural-Related Variables on Melanocyte-Keratinocyte Suspension Transplantation in Nonsegmental Stable Vitiligo: A Clinical and Immunocytochemical Study. El-Zawahry BM; Esmat S; Bassiouny D; Zaki NS; Sobhi R; Saleh MA; Abdel-Halim D; Hegazy R; Gawdat H; Samir N; El-Hawary M; El Maadawi Z; Gouda H; Khorshied M Dermatol Surg; 2017 Feb; 43(2):226-235. PubMed ID: 28157763 [TBL] [Abstract][Full Text] [Related]
96. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study. Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867 [TBL] [Abstract][Full Text] [Related]
97. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Verma R; Grewal RS; Chatterjee M; Pragasam V; Vasudevan B; Mitra D Med J Armed Forces India; 2014 Jan; 70(1):26-31. PubMed ID: 24623943 [TBL] [Abstract][Full Text] [Related]
98. The effect of latanoprost on vitiligo: a preliminary comparative study. Anbar TS; El-Ammawi TS; Abdel-Rahman AT; Hanna MR Int J Dermatol; 2015; 54(5):587-93. PubMed ID: 25545321 [TBL] [Abstract][Full Text] [Related]
99. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. Boersma BR; Westerhof W; Bos JD J Am Acad Dermatol; 1995 Dec; 33(6):990-5. PubMed ID: 7490371 [TBL] [Abstract][Full Text] [Related]
100. Repigmentation patterns induced by NB-UVB and their relationship with melanocytic migration and proliferation in vitiligo. Castanedo-Cázares JP; Cortés-García JD; Fuentes-Ahumada C; Martinez-Rosales K; Torres-Álvarez B Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):269-275. PubMed ID: 27627998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]